Effectiveness of small interfering RNA (siRNA) against the Mcl-1 gene in a canine mammary gland tumor cell line

Research in Veterinary Science

Volumn 87, Issue 1, 2009, Pages 64-66

  Kano, Rui ^a   Yano, Takayuki ^a   Nagamatsu, Kota ^a   Maruyama, Haruhiko ^a   Kamata, Hiroshi ^a   Hasegawa, Atsuhiko ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Apoptosis; Canine mammary gland tumor; Mcl 1; Small interfering RNA (siRNA)

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DOG DISEASE; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TUMOR; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; NEOPLASM PROTEINS; RNA, SMALL INTERFERING;

EID: 67349232739     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.12.006     Document Type: Article

References (12)

1. Beardsley A., Fang K., Mertz H., Castranova V., Friend S., and Liu J. Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. The journal of Biological Chemistry 280 (2005) 3541-3547
2. Brodey R.S., Goldschmidt M.H., and Roszel J.R. Canine mammary, gland neoplasms. Journal of the American Animal Hospital Association 19 (1983) 61-90
3. Danilkovitch-Miagkova A., Miagkov A., Skeel A., Nakaigawa N., Zbar B., and Leonard E.J. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway. Molecular and Cellular Biology 21 (2001) 5857-5868
4. Dorn C.R., Taylor D.O., Schneider R., Hibbard H.H., and Klauber M.R. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute/National Institutes of Health 40 (1968) 307-318
5. Etxebarria A., Landeta O., Antonsson B., and Basañez G. Regulation of antiapoptotic MCL-1 function by gossypol: mechanistic insights from in vitro reconstituted systems. Biochemical Pharmacology 76 (2008) 1563-1576
6. Grone A., Weckmann M.T., Capen C.C., and Rosol T.J. Canine glyceraldehydes-3-phosphate dehydrogenase complementary DNA: polymerase chain reaction amplification, cloning, partial sequence analysis, and use as loading control in ribonuclease protection assays. American journal of veterinary research 57 (1996) 254-257
7. Michels J., Johnson P.W.M., and Packham G. Mcl-1. The International Journal of Biochemistry and Cell Biology 37 (2005) 267-271
8. Nagamatsu K., Tsuchiya F., Oguma K., Maruyama H., Kano R., and Hasegawa A. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line. Research in Veterinary Science. 84 (2006) 49-55
9. Nelson R.W., and Couto C.G. Lymphoma in the cat and dog. Small Animal Internal Medicine 2nd ed. (1998), Mosby St. Louis 876-878
10. Sano J., Oguma K., Kano R., and Hasegawa A. Molecular cloning of canine Mcl-1 gene and its expression in tumor cell lines. Journal of Veterinary Medical Science 65 (2003) 149-151
11. Sorenmo K.U. Canine mammary gland tumors. The Veterinary Clinics of North America; Small Animal Practice; Update in Medical Oncology 33 (2003) 573-596
12. Tsuchiya F., Kano R., Sano J., Oguma K., and Hasegawa A. Apoptosis of canine mammary tumor cells induced by small interfering RNA (siRNA) against Bcl-xL gene. Journal of Veterinary Medical Science 68 (2006) 199-201